Urology · Memphis, TN
NPI
1497860720
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
6029 Walnut Grove Rd, Suite 300
Memphis, TN, 38120
Phone (901) 767-8158
Groups this clinician bills Medicare through
Medicare paid, 2024
$810K
60,292 services
Medicare patients, 2024
1,698
Average age 74
Drug cost, 2024
$9.3M
10,155 prescriptions
Company payments, 2025
$4,218
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark D Greenberger was code J1071 (injection, testosterone cypionate, 1 mg), 38,593 times for 59 patients. In total Mark D Greenberger billed 60,292 services in 177 codes, and Medicare paid $810K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-11-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 38,593 | 59 | $0.02 | $705 |
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 2,646 | 43 | $45.24 | $120K |
| 81003 Clinical Chemistry | Office | 2,636 | 1,403 | $2.15 | $5,672 |
| 82570 Clinical Chemistry | Office | 2,588 | 1,393 | $4.97 | $13K |
| 36415 Venipuncture Blood Collection | Office | 1,755 | 1,072 | $8.43 | $15K |
| 99213 Office E&M - Established | Office | 1,689 | 1,108 | $62.32 | $105K |
| 84153 Clinical Chemistry | Office | 1,356 | 844 | $17.63 | $24K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 1,306 | 172 | $0.11 | $140 |
| 51798 Ultrasound - Nonspecific | Office | 1,101 | 747 | $7.54 | $8,307 |
| 99214 Office E&M - Established | Office | 929 | 724 | $92.41 | $86K |
| 84403 Clinical Chemistry | Office | 800 | 449 | $24.41 | $20K |
| 96372 Injection Administration | Office | 358 | 190 | $10.12 | $3,624 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 239 | 29 | $135.07 | $32K |
| 82565 Clinical Chemistry | Office | 198 | 180 | $4.89 | $969 |
| 36410 Vascular | Office | 193 | 169 | $12.42 | $2,398 |
By year: 2022 $813K for 87,594 services; 2023 $777K for 81,838 services; 2024 $810K for 60,292 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 2,636 | 1,403 | $2.15 | $5,672 |
| 82570 Clinical Chemistry | 2,588 | 1,393 | $4.97 | $13K |
| 36415 Venipuncture Blood Collection | 1,755 | 1,072 | $8.43 | $15K |
| 84153 Clinical Chemistry | 1,356 | 844 | $17.63 | $24K |
| 84403 Clinical Chemistry | 800 | 449 | $24.41 | $20K |
| 82565 Clinical Chemistry | 198 | 180 | $4.89 | $969 |
| 84154 Clinical Chemistry | 182 | 154 | $17.82 | $3,244 |
| 86316 Immunoassay | 126 | 111 | $20.23 | $2,549 |
| 88112 Surgical Pathology Examination | 122 | 118 | $20.08 | $2,449 |
| 84402 Clinical Chemistry | 88 | 83 | $24.15 | $2,125 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark D Greenberger prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,836 prescriptions and refills. In total Mark D Greenberger wrote 10,155 Medicare prescriptions that cost $9.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,836 | 4,821 | 696 | $27K |
| Myrbetriq Mirabegron | 581 | 896 | 189 | $404K |
| Ciprofloxacin Hcl Generic | 550 | 552 | 409 | $3,182 |
| Gemtesa Vibegron | 483 | 698 | 140 | $328K |
| Dutasteride Generic | 443 | 1,120 | 155 | $15K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 414 | 414 | 328 | $3,021 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 392 | 430 | 324 | $1,329 |
| Xtandi Enzalutamide | 358 | 358 | 48 | $4.9M |
| Solifenacin Succinate Generic | 351 | 741 | 135 | $13K |
| Finasteride Generic | 331 | 907 | 106 | $4,436 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 316 | 750 | 130 | $6,879 |
| Orgovyx Relugolix | 283 | 283 | 45 | $721K |
| Testosterone Cypionate Generic | 269 | 490 | 94 | $16K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 265 | 265 | 167 | $3,652 |
| Oxybutynin Chloride Generic | 180 | 369 | 67 | $2,503 |
Brand drugs: - claims; generic drugs: 8,083 claims; opioid claims: 714.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark D Greenberger $4,218 ($4,218 in general payments such as food, travel and fees) from 32 companies. The largest payer was Medtronic, Inc. with $640.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 8 | $640 |
| Sumitomo Pharma America, Inc. 4506.T | 17 | $506 |
| Teleflex LLC TFX | 6 | $429 |
| Janssen Biotech, Inc. JNJ | 9 | $368 |
| Coloplast Corp | 21 | $362 |
| Biotissue Holdings Inc. | 6 | $254 |
| Dendreon Pharmaceuticals LLC | 3 | $213 |
| Procept Biorobotics Corporation PRCT | 1 | $170 |
| Pfizer Inc. PFE | 6 | $128 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $107 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.